CID-16020046

CID-16020046

Identifiers
IUPAC name 4-[4,6-Dihydro-4-(3-hydroxyphenyl)-3-(4-methylphenyl)-6-oxopyrrolo[3,4-c]pyrazol-5(1H)-yl]benzoic acid
CAS Number	834903-43-4
PubChem (CID)	16020046
IUPHAR/BPS	6577
ChemSpider	12543007
ECHA InfoCard	100.233.214
Chemical and physical data
Formula	C25H19N3O4
Molar mass	425.435
3D model (Jmol)	Interactive image
SMILES c5c(O)cccc5C1N(c(cc2)ccc2C(=O)O)C(=O)c4c1c(nn4)-c3ccc(C)cc3
InChI InChI=1S/C25H19N3O4/c1-14-5-7-15(8-6-14)21-20-22(27-26-21)24(30)28(18-11-9-16(10-12-18)25(31)32)23(20)17-3-2-4-19(29)13-17/h2-13,23,29H,1H3,(H,26,27)(H,31,32) Key:VGUQVYZXABOXCX-UHFFFAOYSA-N

CID-16020046 is a compound which acts as an inverse agonist at the former orphan receptor GPR55, and may be the first selective inverse agonist characterised for this receptor. It was found to block a number of GPR55 mediated responses such as wound healing and activation of immune system T-cells and B-cells, as well as showing inverse agonist activity in the absence of GPR55 agonist stimulation. However while it was found to have good selectivity over the related CB₁ and CB₂ cannabinoid receptors as well as a number of other targets, CID-16020046 has not yet been tested against another related receptor GPR18, so its selectivity for GPR55 over this target has not been established.

See also

• CID-85469571
• O-1918
• PSB-SB-487